A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192G
Mark S. Riddle, Milton Maciel, Chad K. Porter, S. Poole, Ramiro L. Gutiérrez, Robert Gormley, Renée M. Laird, Peter J. Sebeny, Kathleen E. Dori, Melissa E. Greenleaf, Fahmida Hoq, George W. Turiansky, Abel Jarell, Douglas Hawk, David R. Tribble, Stephen J. Savarino
Topics & Concepts
Enterotoxigenic Escherichia coliImmunogenicityBacterial adhesinMedicineHeat-labile enterotoxinEnterotoxinFimbriaImmunologyDiarrheaVaccinationMicrobiologyAntigenEscherichia coliInternal medicineBiologyGeneBiochemistryEscherichia coli research studiesViral gastroenteritis research and epidemiologyTransgenic Plants and Applications